Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11449)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Toshikuni N, Arisawa T, Tsutsumi M. Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality. World J Gastroenterol 2014; 20(11): 2876-2887 [PMID: 24659879 DOI: 10.3748/wjg.v20.i11.2876] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i11/2876.htm |
| Number | Citing Articles |
| 1 |
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liver. Current Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
|
| 2 |
Partha K. Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J. Cohen, Humberto E. Behorquez, Ian Carmody, George Loss, Luis A. Balart, Tong Wu, Srikanta Dash, Ranjit Ray. Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis. PLoS ONE 2014; 9(9): e108616 doi: 10.1371/journal.pone.0108616
|
| 3 |
Jana Enderes, Jessica Teschke, Steffen Manekeller, Tim O. Vilz, Jörg C. Kalff, Tim R. Glowka. Chronic Liver Disease Increases Mortality Following Pancreatoduodenectomy. Journal of Clinical Medicine 2021; 10(11): 2521 doi: 10.3390/jcm10112521
|
| 4 |
Allison Dormanesh, Judy Huei-yu Wang, Ranit Mishori, Paula Cupertino, Joshua Longcoy, Seble Kassaye, Linda Kaljee, Coleman Smith, Christopher A. Loffredo. Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviors. Preventive Medicine Reports 2021; 23: 101482 doi: 10.1016/j.pmedr.2021.101482
|
| 5 |
Novie Amelia Chozie, Melati Arum Satiti, Damayanti Rusli Sjarif, Hanifah Oswari, Ni Ken Ritchie. The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience. Blood Research 2022; 57(2): 129 doi: 10.5045/br.2022.2021219
|
| 6 |
Tamami Abe, Hidekatsu Kuroda, Yudai Fujiwara, Yuichi Yoshida, Akio Miyasaka, Naohisa Kamiyama, Yasuhiro Takikawa. Accuracy of 2D shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis C. Journal of Clinical Ultrasound 2018; 46(5): 319 doi: 10.1002/jcu.22592
|
| 7 |
Orla Convery, Siobhan Gargan, Michelle Kickham, Martina Schroder, Cliona O'Farrelly, Nigel J. Stevenson.
The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)‐
α via
signal transducer and activator of transcription (STAT)3 and extracellular signal‐regulated kinase (ERK)–mediated induction of suppressor of cytokine signaling (SOCS)3
. The FASEB Journal 2019; 33(8): 8732 doi: 10.1096/fj.201800629RR
|
| 8 |
José Velosa. Why is Viral Eradication so Important in Patients with HCV-Related Cirrhosis?. Antiviral Therapy 2017; 22(1): 1 doi: 10.3851/IMP3077
|
| 9 |
Chen Zheng, Markus Schneider, Antoine Marion, Iris Antes. The Q41R mutation in the HCV-protease enhances the reactivity towards MAVS by suppressing non-reactive pathways. Physical Chemistry Chemical Physics 2022; 24(4): 2126 doi: 10.1039/D1CP05002H
|
| 10 |
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
|
| 11 |
Si-Yu Liu, Chao Li, Li-Yang Sun, Ming-Cheng Guan, Li-Hui Gu, Dong-Xu Yin, Lan-Qing Yao, Lei Liang, Ming-Da Wang, Hao Xing, Hong Zhu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Xiang-Min Tong, Tian Yang. ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1018396
|
| 12 |
Prabhav Kalaghatgi, Anna Maria Sikorski, Elena Knops, Daniel Rupp, Saleta Sierra, Eva Heger, Maria Neumann-Fraune, Bastian Beggel, Andreas Walker, Jörg Timm, Hauke Walter, Martin Obermeier, Rolf Kaiser, Ralf Bartenschlager, Thomas Lengauer, Luis Menéndez-Arias. Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents. PLOS ONE 2016; 11(5): e0155869 doi: 10.1371/journal.pone.0155869
|
| 13 |
|
| 14 |
María Llanos Valero, Rosario Sabariegos, Francisco J. Cimas, Celia Perales, Esteban Domingo, Ricardo Sánchez-Prieto, Antonio Mas. Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular Relocalization. Antimicrobial Agents and Chemotherapy 2016; 60(6): 3540 doi: 10.1128/AAC.03019-15
|
| 15 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 16 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus. Cancers 2023; 15(20): 4993 doi: 10.3390/cancers15204993
|
| 17 |
Mehlayl Tariq, Abu Bakar Shoukat, Sedrah Akbar, Samaia Hameed, Muniba Zainab Naqvi, Ayesha Azher, Muhammad Saad, Muhammad Rizwan, Muhammad Nadeem, Anum Javed, Asad Ali, Shahid Aziz. Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection. SAGE Open Medicine 2022; 10: 205031212211059 doi: 10.1177/20503121221105957
|
| 18 |
Kosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Naotaka Shimozato, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Kenichiro Seki, Yukihisa Fujinaga, Yuki Tsuji, Takuya Kubo, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Akira Mitoro, Tsuyoshi Mashitani, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji. Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6481
|
| 19 |
Junna Wang, Jiajun Li, Quan Zhou, Dandan Zhang, Qiu Bi, Yulin Wu, Wenxiang Huang. Liver stiffness measurement predicted liver‐related events and all‐cause mortality: A systematic review and nonlinear dose–response meta‐analysis. Hepatology Communications 2018; 2(4): 467 doi: 10.1002/hep4.1154
|
| 20 |
Siyu Liu, Liyang Sun, Lanqing Yao, Hong Zhu, Yongkang Diao, Mingda Wang, Hao Xing, Wan Yee Lau, Mingcheng Guan, Timothy M. Pawlik, Feng Shen, Min Xu, Xiangmin Tong, Tian Yang. Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis. Journal of Clinical Medicine 2022; 11(17): 5075 doi: 10.3390/jcm11175075
|
| 21 |
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim. Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study. Journal of Korean Medical Science 2019; 34(41) doi: 10.3346/jkms.2019.34.e264
|
| 22 |
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C. 2020; doi: 10.5772/intechopen.83609
|
| 23 |
Erin Kelty, Gary Hulse, David Joyce, David B. Preen. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality. CNS Drugs 2020; 34(6): 629 doi: 10.1007/s40263-020-00719-3
|
| 24 |
José Carlos Rodrigues Nascimento, Lianna C Pereira, Juliana Magalhães C Rêgo, Ronaldo P Dias, Paulo Goberlânio B Silva, Silvio Alencar C Sobrinho, Gustavo R Coelho, Ivelise Regina C Brasil, Edmilson F Oliveira-Filho, James S Owen, Pierluigi Toniutto, Reinaldo B Oriá. Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis. World Journal of Gastroenterology 2021; 27(11): 1064-1075 doi: 10.3748/wjg.v27.i11.1064
|